Objective-Current experimental models of abdominal aortic aneurysm (AAA) do not accurately reproduce the major features of human AAA. We hypothesized that blockade of TGFβ (transforming growth factor-β) activity-a guardian of vascular integrity and immune homeostasis-would impair vascular healing in models of nondissecting AAA and would lead to sustained aneurysmal growth until rupture. Approach and Results-Here, we test this hypothesis in the elastase-induced AAA model in mice. We analyze AAA development and progression using ultrasound in vivo, synchrotron-based ultrahigh resolution imaging ex vivo, and a combination of biological, histological, and flow cytometry-based cellular and molecular approaches in vitro. Systemic blockade of TGFβ using a monoclonal antibody induces a transition from a self-contained aortic dilatation to a model of sustained aneurysmal growth, associated with the formation of an intraluminal thrombus. AAA growth is associated with wall disruption but no medial dissection and culminates in fatal transmural aortic wall rupture. TGFβ blockade enhances leukocyte infiltration both in the aortic wall and the intraluminal thrombus and aggravates extracellular matrix degradation. Early blockade of IL-1β or monocyte-dependent responses substantially limits AAA severity. However, blockade of IL-1β after disease initiation has no effect on AAA progression to rupture. Conclusions-Endogenous TGFβ activity is required for the healing of AAA. TGFβ blockade may be harnessed to generate new models of AAA with better relevance to the human disease. We expect that the new models will improve our understanding of the pathophysiology of AAA and will be useful in the identification of new therapeutic targets. Visual Overview-An online visual overview is available for this article. rather progresses to a complete rupture of the thin aortic wall, usually at a stage of advanced aortic dilatation.
T he occurrence of abdominal aortic aneurysm (AAA) is a significant cause of morbidity and mortality in Western countries. According to the UK National Health Service AAA screening program, the prevalence of AAA is 1.2% in all men at age 65 irrespective of any other risk factor. 1 AAA affects a much larger proportion of men >65 years of age, particularly in the presence of a family history of AAA and a positive history of smoking. 1, 2 In contrast, a history of diabetes mellitus is associated with a strong protection against the occurrence and progression of AAA.
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AAA is responsible for >11 000 deaths per year in the United States and has been consistently found to resist medical treatment. Aortic wall repair through either endovascular or open surgical procedures is the only option available, with a relatively high risk of early or late morbidity and mortality. 2, 4 The pathophysiology of AAA is complex and associates proteolysis of the extracellular matrix (ECM), degeneration and loss of vascular smooth muscle cells (VSMCs), alteration of endothelial cells, and formation of intraluminal thrombus (ILT), along with an infiltration and activation of innate and adaptive immune cells. 5 The absence of resolution of those processes leads to progressive AAA growth and culminates in AAA rupture when the aortic wall is unable to sustain the hemodynamic overload. Of note, in contrast to thoracic aortic aneurysms, 6 medial dissection is a rare event in AAA, which rather progresses to a complete rupture of the thin aortic wall, usually at a stage of advanced aortic dilatation. 7 A variety of animal models have been developed to better understand the pathophysiology of AAA. Strikingly, however, most models fail to reproduce or combine the major features of human AAA. Currently, most experimental models of AAA are performed in rodents, particularly mice, and can be divided into 2 main categories. 8 The first category includes models that induce medial aortic dissection rather than true aortic aneurysmal dilatation, and lead to hemorrhage into a false channel (intramural hemorrhage), which may ultimately rupture. This is the case of the angiotensin II-infusion model, initially described by the Daugherty et al 9 groups in mice with genetic susceptibility to hyperlipidemia and atherosclerosis, 10 but also models of lysyl oxidase inhibition [11] [12] [13] and those combining mineralocorticoid receptor activation with high salt.
14 Despite the many advantages of those dissecting AAA models, medial dissection is not a major feature of human AAA and is rarely an initiating event in the disease process. 8 Rather, most human AAAs are characterized by aneurysmal dilatation of the aorta without false channel formation and culminate in a rupture of the thin aortic wall. 7 The second category of experimental AAAs includes models that induce abdominal aortic dilatation without medial dissection, as is the case for the widely used elastase-induced or calcium chloride-induced AAA models. 8 However, those models produce moderate aortic dilatation in mice and do not induce aortic wall rupture. Finally, although leukocyte infiltration, ECM degradation, and medial degeneration are observed in almost all the abovementioned models, ILT is frequently absent. Thus, there is currently no validated AAA model in mice that reproduces and combines the major features of human AAA: sustained aneurysmal dilatation of the native aorta without false lumen formation, associating ECM degradation, medial degeneration, leukocyte infiltration, ILT formation, and culminating in transmural rupture of the thin aortic wall.
Studies on the mechanisms of aortic aneurysm and dissection have shed light on the importance of TGFβ (transforming growth factor-β) activity in the maintenance of aortic wall integrity. In mice, genetic disruption of TGFβ signaling in VSMCs early during the disease process promotes the development of aneurysms and dissections in the thoracic aorta. 15, 16 Furthermore, blockade of TGFβ activity aggravates ECM degradation, medial degeneration, leukocyte infiltration, and increases the susceptibility to both thoracic and abdominal aortic dissection in mice infused with angiotensin II. 17, 18 Finally, promotion of TGFβ activity limits the development and expansion of experimental AAAs. 19 Based on these observations, we hypothesized that TGFβ may be the critical factor that maintains aortic wall integrity in mouse models of nondissecting AAA (eg, elastase-induced abdominal aortic injury) and that blockade of TGFβ activity in those settings would aggravate aneurysmal aortic dilatation, induce ILT formation, and promote aortic rupture, thereby reproducing the major features of complicated human AAA.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Inhibition of TGFβ Activity Induces Abdominal Aortic Rupture After Elastase Injury
We combined topical application of elastase on the abdominal aorta [20] [21] [22] with systemic blockade of TGFβ activity using a neutralizing mouse monoclonal anti-TGFβ. 17, 18 As already described, [20] [21] [22] periaortic elastase significantly increased aortic diameter (compared with inactive elastase) as assessed by serial in vivo ultrasound imaging ( Figure 1A and 1B) and direct caliper measurement of the external diameter of the aorta at the time of euthanization ( Figure 1C ). Interestingly, although aortic dilatation did not progress after day 7 in the group receiving active elastase only ( Figure 1B 
Synchrotron-Based Ultrahigh Resolution Imaging Reveals Features of Human AAA
To characterize this new mouse model of AAA rupture, we used synchrotron-based ultrahigh resolution ex vivo imaging on tissue samples from mice that had been euthanized at different time points and assessed in details aortic diameter, elastin degradation, adventitial thickness, and the occurrence of ILT, medial dissection, or rupture (Figures 2 and 3) . The medial perimeter was highest for locations at which elastin degradation was most outspoken ( Figure 2J and 2K) still increased progressively at later time points. We observed that animals with ruptured AAA had substantially larger medial perimeters ( Figure 2C ), extensive elastin degradation ( Figure 2F ), and larger ILT volumes ( Figure 2I ) but only moderate although significant increase in adventitial thickness ( Figure 2L ) compared with animals with intact AAA. Synchrotron-based ultrahigh resolution analysis throughout the length of the AAA ruled out the occurrence of medial delamination/dissection and attributed fatal aortic death to complete transmural rupture of the media ( Figure 3A ). ILT presence was found both in the main aorta and the side branches ( Figure 3A ; Figure IVB and IVC in the onlineonly Data Supplement) and was confirmed on aortic sections ( Figure 3B ). ILT stained positive for platelets (anti-CD41), leukocytes (Hoechst), and fibrin/fibrinogen as shown by confocal microscopy ( Figure 3C ). Platelets were also found in the aortic wall, in between the medial and adventitial layers, probably because of hemorrhage ( Figure 3D ).
Aortic Tissue Remodeling in the Elastase/Anti-TGFβ Model
By microscopy on sections from day 14, we confirmed that the combination of elastase and anti-TGFβ significantly enhanced the accumulation of blood/iron in the aortic wall ( Figure 4A ) and induced profound aortic wall remodeling with smooth muscle cell loss in the media ( Figure 4B ), adventitial neovascularization ( Figure 4B ), increased accumulation of apoptotic cells ( Figure 4C ), as well as increased matrix metalloproteinase activity ( Figure 4D ) and reduced collagen content ( Figure 4E ), as compared with the elastase-only group. Proliferation as assessed by Ki67 staining was detected in both immune and stromal cells of vessels subjected to elastase application but was not different between elastase and elastase+anti-TGFβ groups ( Figure V in the online-only Data Supplement). 
Inhibition of TGFβ Activity Increases Immune Cell Accumulation in the Aorta After Elastase Injury
Inflammation is another feature of AAA remodeling and rupture in humans. 5 Using fluorescent microscopy and flow cytometry analysis, we characterized the inflammatory infiltrate present in aortic samples at day 14. TGFβ inhibition after periaortic elastase application dramatically increased the accumulation of T cells, macrophages, and neutrophils, as compared with aortic samples treated with elastase only ( Figure 5 ). Flow cytometry analysis suggested that macrophages were mostly derived from monocytes, given their high expression of Ly6B ( Figure 5D ) and that the T-cell population was composed of both CD4 + and CD8 + cells with an activated phenotype (CD69 + ; Figure 5D ). We also noticed that, as described in human AAA, the ILT of mice treated with elastase+anti-TGFβ was rich in neutrophils ( Figure 5C ). + monocytes that differentiate under the control of C/EBPβ, home to injured tissues during the healing phase, and play a crucial role in tissue fibrosis. 23 SatM do not produce TGFβ; however, C/EBPβ deficiency, which eliminates SatM, is associated with substantial reduction of TGFβ production. 23 Therefore, we tested the impact of TGFβ blockade on the accumulation of SatM after elastase injury. Interestingly, we found a substantial reduction of SatM in the bone marrow, blood, and aortic wall of mice treated with neutralizing anti-TGFβ antibody and periaortic elastase, compared with periaortic elastase only ( Figure VI in the online-only Data Supplement). Our results support an important role for TGFβ in SatM homeostasis, with potentially important consequences on the healing response.
TGFβ Blockade Limits the Accumulation of Profibrotic Segregated Atypical Monocytes
Monocytes/Macrophages Are Necessary for the Induction of AAA Rupture After Elastase and Anti-TGFβ Treatment
Given the imbalance between inflammatory monocytes and SatM in mice treated with anti-TGFβ, we hypothesized that monocyte/macrophage depletion using clodronate liposomes would limit disease severity and reduce the occurrence of aortic rupture. Treatment with clodronate liposomes effectively depleted systemic monocytes ( Figure 6A ) and aortic macrophages ( Figure 6B ) in comparison with phosphate-buffered saline-loaded liposomes. Monocyte/macrophage depletion did not abrogate aneurysm development ( Figure 6C ) but led to a marked reduction of AAA severity ( Figure 6C ) and completely protected against AAA rupture ( Figure 6D ). This was associated with a significant reduction of elastin degradation ( Figure 6E ) and increased collagen content ( Figure 6F ).
Role of IL-1β in the Initiation Versus Progression of AAA
To gain more insight into the inflammatory response, we analyzed mRNA expression of cytokines (by quantitative polymerase chain reaction) in the aortic tissue and found that both proinflammatory (tumor necrosis factor, interleukin [IL]-6, IL-1β, and CXCL1) and anti-inflammatory (TGFβ and IL-10) cytokines were induced after elastase injury ( Figure VII in the online-only Data Supplement). Tumor necrosis factor, IL-1β, and CXCL1 reached high levels at day 7, but their expression was attenuated at day 14. IL-6 expression showed a late increase between day 7 and day 14. IL-10 and TGFβ increased at day 7, with variable expression of IL-10 at day 14. TGFβ blockade on top of elastase application led to sustained elevations and higher levels of IL-1β, CXCL1, and IL-6 at day 14 after aortic injury but did not alter tumor necrosis factor and IL-10 expression. We also detected a slightly higher aortic TGFβ expression in the elastase+anti-TGFβ at day 14, compared with the elastase-only group.
The kinetics of IL-1β expression in the aortic wall suggested a differential effect in the initiation versus progression of AAA. To directly assess the implication of IL-1β in aortic dilatation and rupture, we compared IL-1β knockout (KO) and wild-type mice. We confirmed the absence of IL-1β in the plasma of IL-1β KO mice and found that CXCL1 and IL-10 were also significantly reduced, suggesting a role for IL-1β in the production of these cytokines ( Figure ) . B, Representative immunofluorescent staining of macrophages in the aorta on day 14 after surgery (n=7-9 per group). C, Representative macroscopic picture and quantification of aortic perimeter of aorta at day 14 after surgery (n=7-9 per group). Mann-Whitney U test. *P<0.05 liposome-phosphate-buffered saline (PBS) vs liposome-clodronate. D, Survival curves of mice injected with liposomes (n=7-9 mice per group). Log-rank, Mantel-Cox test. **P<0.01 liposome-PBS vs liposome-clodronate. E and F, Analysis of elastin and collagen degradation using Orcein staining (E) and Sirius red (F), respectively. Mann-Whitney U test (n=7-9 mice per group). In E and F, *P<0.05 liposome-PBS vs liposome-clodronate. antibody starting at day 7 after elastase+anti-TGFβ did not the limit the progression of established AAA toward fatal rupture ( Figure 7C ). Taken together, our data indicate that IL-1β is important for the initiation of AAA but is dispensable for the progression and complications of established AAA.
Discussion
Major features of human AAA include ECM degradation, medial smooth muscle cell loss and degeneration, infiltration and activation of immune cells, ILT formation, progressive aortic dilatation in the absence of medial dissection, and finally aortic wall rupture. It is noteworthy that despite the variety of experimental models of AAA, none has been reported to combine the major features of human AAA. Most models either induce early medial dissection, not transmural aortic wall rupture, or lead to self-contained aortic dilatation. Furthermore, most models do not induce ILT formation. A rare occurrence of aortic rupture has been reported in elastase-induced AAA in rats, not mice, but those rare ruptures occur early after elastase application and are because of an overactive exogenous elastase rather than a progressive aneurysmal aortic disease that culminates in aortic wall rupture. Recently, Lu et al 22 reported the development of a chronic model of AAA in mice after a combination of periaortic elastase application and continuous oral administration of the lysyl oxidase inhibitor BAPN (beta-aminopropionitrile). AAA development in that model was associated with thrombus formation and spontaneous rupture. Despite those interesting humanlike aneurysm features, the authors provided no evidence for the absence of medial dissection, and there was no evidence that the few late ruptures had arisen from the aortic wall itself; in fact, some deaths were attributed to rupture or dissection of small arteries. 22 Moreover, BAPN is known to induce medial dissections, not transmural ruptures, which lead to intramural, not intraluminal, hemorrhage and thrombus formation. [11] [12] [13] In contrast to previous models, the AAA model we describe here in detail associates all the major features of human AAA and is potentially of great interest to our understanding of the pathophysiology of AAA development, progression, and complications.
It is remarkable to observe that the transition from a model inducing a self-contained aortic dilatation to a human-like model of sustained aneurysmal growth culminating in rupture is because of the blockade of a single cytokine, TGFβ. This supports a critical role of TGFβ signaling in the maintenance of aortic wall integrity and the protection against AAA progression and complications. Mutations in the TGFβ signaling pathway are responsible for severe forms of thoracic aortic aneurysms and dissections in humans, 24 and some studies reported associations between single-nucleotide polymorphisms in the TGFβ signaling components and AAA. 25 Moreover, human AAA biopsies frequently show loss of 1 copy of TGFβ receptor type 2 exon 8 in association with a substantial reduction of gene expression, suggesting an acquired impairment in the TGFβ pathway and local downregulation of TGFβ signaling. 26 The major sources of TGFβ during AAA development remain to be identified. Immune cells, VSMCs, (myo)fibroblasts, and platelets may all contribute to TGFβ production.
How does TGFβ activity control AAA dilatation and propensity to rupture? TGFβ is well known to control major biological processes involved in AAA, including ECM remodeling, VSMC survival and proliferation, and the activation of the immuno-inflammatory response. 25 We show here that at least some of the protective effect occurs through the control of the innate immune response and more particularly, the balance between inflammatory monocytes/macrophages and profibrotic SatM. The specific role of the latter monocyte subset will require further investigation. Moreover, other innate immune cells like neutrophils, or adaptive immune cells like T cells, may cooperate with monocytes/macrophages and probably contribute to the process. Note that our study does not exclude a role for TGFβ activity in vascular cells and (myo) fibroblasts. However, deletion of TGFβ receptor signaling in VSMC did not lead to aggravation of AAA after elastase application in mice. 27 The latter result is surprising given the major role of VSMC-restricted TGFβ signaling in the protection against thoracic aortic aneurysms. 15, 16, 28 Our study identifies IL-1β as an important cytokine involved in the prevention of AAA development, which is an agreement with previous studies performed in less-severe models of the disease.
29 Surprisingly, however, IL-1β blockade did not affect the progression of established AAA toward rupture, suggesting a limited role (if any) of IL-1β in advanced stages of the disease. The role of IL-1 pathway in human AAA is not well understood. Genetic upregulation of IL-1 receptor antagonist in humans is associated with increased, not reduced, susceptibility to AAA. 30 Moreover, a recent placebo-controlled randomized trial failed to show any benefit of canakinumab (a neutralizing monoclonal anti-IL-1β antibody) on AAA progression in patients with small AAAs (between 40 and 50 mm; clinicaltrials.gov, NCT02007252). The trial included a limited number of patients in each group (31 Canakinumab and 33 placebo), and only 2 of 3 patients completed the 12-month treatment period. These unexpected human data are in disagreement with previous mouse data that suggested a detrimental role for IL-1 signaling in the progression of AAA, using the elastase model. 29 However, they seem to be in agreement with our findings of a limited role of IL-1β in established AAA, using the present elastase+anti-TGFβ model, further highlighting the clinical translational relevance of this new mouse model.
Another important point to consider is the chronicity and sustainability of AAA development and growth over time.
Most available experimental models of nondissecting AAA induce a development of AAA for 7 days and are rapidly selfcontained with no or little AAA progression thereafter; in fact, they tend to heal with time in the absence of sustained injury. The elastase+BAPN model described recently allows the development of a chronic aortic aneurysm and is worth of further consideration. 22 However, there is no solid evidence yet that it is not driven by early medial dissection or that sudden death is because of true aortic wall rupture. In this context, our identification of TGFβ as a critical mediator of AAA healing is likely to open new avenues for the development of chronic models of nondissecting AAA characterized by an impaired healing process and sustained growth, until aortic rupture. Our current elastase/anti-TGFβ model produces a human-like AAA and a high percentage of AAA rupture within 14 days. We think that this model can be adapted to produce a nonresolving inflammation that will sustain AAA growth for a longer period, for example, through controlled blockade of TGFβ over time (varying the frequency and dose of anti-TGFβ), better mimicking the progression of human AAA. It is expected that in such a chronic smoldering model, the pathogenic mechanisms of AAA growth may differ from our current understanding of disease pathogenesis.
Finally, the new model described here may be useful to address the role of specific features of AAA, for example, ILT formation in AAA progression and susceptibility to rupture. Moreover, it will be interesting to examine whether blockade of TGFβ activity may be useful in promoting features of human-like AAA in other experimental models, like the CaCl2 model.
In conclusion, we have shown that current experimental mouse models of AAA can be improved to better reproduce major features of human AAA and may be harnessed to predict response to therapy in the human disease setting. We expect that optimized models will provide a better understanding of the pathophysiology of AAA and will be useful to identify and test new and relevant therapeutic targets.
